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Myocardial Fibrosis Identified by Cardiac Magnetic
Resonance Late Gadolinium Enhancement Is
Associated With Adverse Ventricular Mechanics and
Ventricular Tachycardia Late After Fontan Operation
Rahul H. Rathod, MD, Ashwin Prakash, MD, Andrew J. Powell, MD, Tal Geva, MD
Boston, Massachusetts
Objectives The purpose of this study was to evaluate the relationship between myocardial fibrosis identified by cardiac magnetic
resonance (CMR) and ventricular performance and arrhythmias in patients late after the Fontan operation.
Background Patients who have undergone the Fontan palliation may develop ventricular dysfunction and arrhythmias, but
the mechanisms and risk factors are poorly defined.
Methods All patients who have had a Fontan operation and a CMR study with the myocardial delayed-enhancement tech-
nique from January 2002 to November 2008 were retrospectively identified.
Results Of 90 patients (mean age at study was 23.1  10.9 years), 25 (28%) had positive late gadolinium enhance-
ment (LGE) in the ventricular myocardium. Patients with positive LGE had lower mean ejection fraction (45% vs.
56%; p  0.001), increased median end-diastolic volume (100 ml/body surface area [BSA]1.3 vs. 82 ml/BSA1.3;
p  0.004), increased median ventricular massi (63 g/BSA
1.3 vs. 45 g/BSA1.3; p  0.001), higher frequency of
regional wall motion abnormalities (52% vs. 28%; p  0.05), and higher frequency of nonsustained ventricular
tachycardia (NSVT) (36% vs. 11%; p  0.01). Multivariate regression analysis demonstrated that more extensive
positive LGE, expressed as percent LGE of total myocardial mass, was associated with lower ejection fraction
(p  0.002), increased end-diastolic volume (p  0.001), increased massi (p  0.001), and a higher frequency
of NSVT (odds ratio 1.2; 95% confidence interval: 1.1 to 1.4; p  0.006).
Conclusions In this cohort of late Fontan survivors, myocardial fibrosis was common and associated with adverse ventricular
mechanics and a higher prevalence of NSVT. Further studies are warranted to examine the utility of LGE for risk
stratification and treatment of ventricular arrhythmia and dysfunction in Fontan patients. (J Am Coll Cardiol
2010;55:1721–8) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.12.036d
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whe Fontan procedure is the most common surgical palli-
tion in patients with a functional single ventricle. Although
dvances in medical and surgical management of these
atients have dramatically improved the prognosis in young
hildren and adolescents (1), adverse outcomes become
ncreasingly frequent with age and are common in adult-
ood (2,3). Myocardial fibrosis has been implicated as a
otential contributor, but evidence has been scant, in part
ue to lack of precise quantitative in vivo methods by which
o detect it.
Myocardial delayed enhancement (MDE) is a cardiac
agnetic resonance (CMR) technique that detects myocar-
rom the Department of Cardiology, Children’s Hospital Boston, and the Depart-
ent of Pediatrics, Harvard Medical School, Boston, Massachusetts. This study was
upported by the Higgins Family Noninvasive Cardiac Imaging Research Fund.L
Manuscript received September 22, 2009; revised manuscript received November
3, 2009, accepted December 21, 2009.ial fibrosis and infarction. The technique has been vali-
ated by studies that correlated the finding of late gadolin-
um enhancement (LGE) with the presence and extent of
yocardial fibrosis detected by histology in animal models
nd in humans (4–6). The majority of the investigations on
GE have been in the context of acquired adult heart
isease. In the congenital heart disease population, positive
GE has been described in patients after tetralogy of Fallot
epair and after atrial redirection surgery for transposition of
he great arteries (7,8). In these cohorts, positive LGE has
een associated with adverse ventricular mechanics, exercise
ntolerance, and arrhythmias. The impact of myocardial
brosis on cardiac performance and clinical outcomes in
atients with a functional single ventricle late after the
ontan operation is not known. The purpose of this study
as to characterize the frequency, location, and patterns of
GE and to evaluate the relationship between LGE and
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Myocardial Fibrosis in Fontan April 20, 2010:1721–8ventricular performance and ar-
rhythmias in patients late after the
Fontan operation.
Methods
Patients. A database search iden-
tified all patients who had under-
gone a Fontan operation and had
a CMR study between January
2002 and November 2008. Among
these, patients were included in
the study if MDE acquisitions
were technically successful. If a
patient had multiple CMR stud-
ies using the MDE technique,
only the most recent study was
used for analysis. The study was
approved by the Scientific Review
Committee of the Department of
Cardiology and by the Children’s
ospital Boston Committee on Clinical Investigation.
linical variables. Demographic and clinical variables
ere abstracted from the medical records. Ventricular mor-
hologies were classified as left ventricular, right ventricular
RV), or mixed (e.g., unbalanced atrioventricular canal).
entricular type was classified as mixed if both ventricles
ad an end-diastolic volume larger than a z score of –4.
ublished normative data from Alfakih et al. was used for
entricular z score calculations (9). Type of surgical pallia-
ion was classified into 1 of 4 Fontan types: lateral tunnel,
ight atrium-to-pulmonary artery anastomosis, right
trium-to-right ventricle connection, or extracardiac con-
uit. Collected surgical variables included age at Fontan,
ime since Fontan, history of Fontan revision, number of
alliations before CMR (divided into those with and with-
ut cardiopulmonary bypass), and age at volume unloading
urgery (e.g., bidirectional Glenn or similar procedure).
MR technique. Studies were performed with commer-
ially available 1.5-T scanners (GE Medical Systems, Mil-
aukee, Wisconsin; and Philips Healthcare, Best, the
etherlands). The details of the CMR protocols and MDE
cquisitions used in our laboratory for assessment of patients
ith congenital heart disease have been published (10–12).
he MDE technique has evolved during the study period as
echnologic advances became available. A representative
rotocol comprised an inversion-recovery prepared, phase-
ensitive, electrocardiogram-triggered, breath-hold seg-
ented, fast-gradient echo pulse sequence in the short-axis
lanes acquired 15 to 20 min after injection of 0.2 mmol/kg
f gadopentetate dimeglumine (Magnevist, Berlex Labora-
ories, Wayne, New Jersey). Image data were acquired in
iastole in every other beat. Imaging parameters were as
ollows: repetition time 5.9 ms; echo time 3.5 ms; flip angle
Abbreviations
and Acronyms
CMR  cardiac magnetic
resonance
EDV  end-diastolic volume
EF  ejection fraction
EFE  endocardial
fibroelastosis
ESV  end-systolic volume
LGE  late gadolinium
enhancement
MDE  myocardial delayed
enhancement
NSVT  nonsustained
ventricular tachycardia
RV  right ventricular
RWMA  regional wall
motion abnormalities
SV  stroke volume0°; field-of-view 260 260 mm; slice thickness 7 to 8 mm; veceiver bandwidth 345.5 Hz; matrix 144 144; and spatial
esolution 1.8  1.8  7 to 8 mm, reconstructed to 1.0 
.0  7 to 8 mm. Inversion times were selected using an
nversion-recovery fast multishot echo-planar imaging
Look–Locker sequence) to optimally null the signal of
ormal myocardium. Post-acquisition analysis of LGE and
entricular size and function were done using commercially
vailable software packages (QMass version 7.0, Medis
edical Imaging Systems, Leiden, the Netherlands).
GE analysis. On the basis of visual assessment, patients
ere divided into 2 groups according to the presence or
bsence of LGE in the ventricular myocardium. LGE was
urther characterized by spatial location, pattern, and LGE
uantification. Spatial location of LGE in the ventricular
yocardium was categorized into 1 or more of the following
ocations: free wall, septum, apex, papillary muscles, trabe-
ulations, septal insertion, and surgical sites. Patterns of
GE were categorized as transmural, subendocardial, sub-
picardial, and speckled. A transmural pattern of LGE
equired involvement of 100% of the ventricular wall thick-
ess. Subendocardial patterns had LGE in the inner 50% of
he ventricular wall or had LGE lesions contiguous with the
ndocardium. Patients with circumferential subendocardial
atterns of LGE were further classified as having endocar-
ial fibroelastosis (EFE) (13). Subepicardial patterns had
GE predominantly in the outer 50% of the ventricular wall
r had LGE lesions contiguous with the epicardium.
atients were categorized as speckled if the LGE pattern
as characterized by multiple small foci of enhancement as
escribed by Babu-Narayan et al. (7). For categorization of
GE locations and patterns, each distinct LGE lesion was
ounted. LGE was quantified by the percent LGE of
entricular mass. Percent LGE was calculated by a single
bserver (R.H.R.) using the previously reported and histo-
ogically verified full-width at half-maximum technique (4).
ontours were manually adjusted to avoid false identifica-
ion of artifacts as LGE. The identified LGE was then
uantified as a mass and expressed as a percentage of the
otal ventricular mass. The total ventricular mass was
alculated using the Simpson method based on the contours
rom the LGE acquisition images. Patients with EFE and
GE in the septal insertion and surgical sites were re-
ontoured to allow for the calculation of percent LGE
ithout EFE, percent LGE without septal insertion, and
ercent LGE without surgical sites. In 12 randomly selected
atients with positive LGE, the percent LGE measure-
ents were repeated by a second blinded observer (A.P.)
sing the full-width at half-maximum technique to assess
nterobserver variability.
entricular size and function. Ventricular volumes and
unction were analyzed by manual tracing of endocardial
nd epicardial borders on each short-axis steady-state free
recession cine slice as previously described (10). The
impson method was applied to calculate end-diastolic
olume (EDV), end-systolic volume (ESV), ejection frac-
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April 20, 2010:1721–8 Myocardial Fibrosis in Fontanion (EF), stroke volume (SV), ventricular mass, and mass-
o-volume ratio. In patients whose ventricular type was
ategorized as mixed, ventricular volumes and mass were
ummed to allow for calculation of total EDV, ESV, EF,
V, and mass-to-volume ratio. If the ventricular type was
ategorized as left ventricular or RV, only the dominant
entricle was used for data analysis. In order to account for
ariations related to body size, SV was indexed to body
urface area (BSA), and EDV, ESV, and ventricular mass
ere indexed to BSA raised to the 1.3 power (14). To allow
omparison with other studies, the univariate results for
entricular volumes and mass were also reported as indexed
o BSA alone.
The cine steady-state free precession acquisitions in long-
nd short-axis views were visually reviewed to identify
egional wall motion abnormalities (RWMAs). RWMAs
ere classified as hypokinesis, akinesis, and dyskinesis. The
orresponding cine and MDE images were compared to
etermine whether RWMA spatially corresponded to re-
ions of positive LGE.
rrhythmia history. Each patient’s arrhythmia history was
ompiled by review of Holter monitors, electrocardiograms,
lectrophysiology catheterizations, and clinic notes. Epi-
odes of atrial ectopy, atrial fibrillation, atrial flutter, su-
raventricular tachycardia, ventricular ectopy, nonsustained
entricular tachycardia (NSVT), sustained ventricular
achycardia, arrhythmia-related cardiac arrest, and electro-
hysiology studies were recorded. Pacemaker or defibrillator
lacement, heart transplantation, or death occurring after
he CMR study was also documented.
xercise testing. Metabolic exercise testing data were in-
luded if the exercise test occurred within 1 year of the
MR study and if the patient reached maximal aerobic
ffort. Maximal aerobic effort was defined as a respiratory
xchange ratio of 1.09 or if the patient reached 95% of
redicted heart rate. Studies with submaximal aerobic effort
ere not included to eliminate bias from factors unrelated to
he patient’s Fontan cardiovascular system (e.g., leg pain) (15).
tatistical analysis. Categorical data were described as
umber (percent). Nominal data were compared using the
earson chi-square test or Fisher exact test. Normally
istributed continuous variables were described as mean 
D and compared using the Student t test. Non-normally
istributed continuous data were described as median (in-
erquartile range [IQR]), and comparisons between sub-
roups were made using the Mann-Whitney U test.
Multivariate linear and logistic regression analysis with
orward stepwise selection was used to investigate associa-
ions of LGE patterns, LGE locations, percent LGE, and
he variables listed in Table 1 with each dependent outcome
ariable (EF, EDVi, ESVi, massi, and NSVT). The analysis
ncluded the entire study group.
Multivariate logistic regression with forward stepwise
election was used to investigate why patients did or did not
ave the LGE technique performed and included variables
uch as age at Fontan, age at CMR, sex, ventricular type, sontan type, history of volume unloading surgery, and
hether study occurred during the first or second half of the
tudy period.
All statistical tests were 2-sided, and results were consid-
red statistically significant if p 0.05. All data analysis was
erformed using SPSS version 15.0 (SPSS Inc., Chicago,
llinois).
esults
atient characteristics. A total of 294 CMR studies per-
ormed on 205 patients who underwent the Fontan opera-
ion were reviewed. Among those studies, MDE imaging
as performed and deemed technically adequate in 103
xaminations from 90 patients. These patients comprise the
tudy group. Table 1 summarizes patient characteristics and
ompares between those without and with positive LGE.
hen comparing patients without and with LGE, there
ere no significant differences in demographics, anatomic
iagnoses, type of Fontan, or other patient characteristics.
There were 115 Fontan patients who had a CMR study
ithout the MDE technique during the study period and,
herefore, were not included in the study. When comparing
he Fontan patients who had a CMR exam with and
ithout the MDE technique, patients who did not have the
DE technique were younger at the time of their last
MR (age 17.5  8.8 years vs. 23.1  10.9 years; p 
.001), closer in time to their Fontan operation (age 11.6 
.8 years vs. 15.7  6.4 years; p  0.001), and more likely
o have had volume unloading surgery (57% vs. 37%; p 
.007). There were no other significant differences in
emographics, anatomic diagnoses, type of Fontan, or other
atient characteristics between included and excluded pa-
ients. Similarly, there were no significant differences in
entricular parameters, including EDVi, ESVi, EF, SVi,
assi, and mass-to-volume ratio. Multivariate logistic re-
ression was performed to identify the associations why
atients did not have the MDE technique performed. In the
nal model, patients were more likely to have the MDE
echnique performed if they had their CMR exam during
he later half of the study period (odds ratio [OR]: 11.6;
5% confidence interval [CI]: 4.9 to 28.0; p  0.001) or if
hey were older at the time of CMR (OR: 1.1; 95% CI: 1.1
o 1.2; p  0.001).
GE characterization. Among the study group, positive
GE was observed in 25 patients (28%). In patients with
ositive LGE, median percent LGE was 5.3% (interquartile
ange 3.3% to 9.8%). Measurements were repeated by a
linded second observer in 12 of 25 patients with LGE. The
nterobserver variability between the 2 observers was good,
ith a 2.5% mean difference between paired measurements
95% CI: –1.6% to 6.7%; p  0.21).
Counting each discrete lesion separately, LGE was found
n the following locations: 64% (n  16) in the free wall of
he primary ventricle, 36% (n  9) in the free wall of the
econdary ventricle, 16% (n  4) in the ventricular septum,
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Myocardial Fibrosis in Fontan April 20, 2010:1721–86% (n  4) at the site of ventricular septal insertion, 12%
n  3) in papillary muscles, 8% (n  2) in the ventricular
pex, and 8% (n  2) at surgical sites. Examples of typical
ocations and patterns of LGE are shown in Figure 1.
ounting each discrete LGE lesion separately, 40% (n 
0) of patients had transmural LGE patterns, 32% (n  8)
emonstrated subendocardial LGE, 20% (n  5) had
ubepicardial LGE, 16% (n  4) showed EFE, and 12%
ad speckled LGE (n  3).
entricular size and function. Univariate analyses of
entricular size and function are summarized in Table 2.
atients with positive LGE in the ventricular myocar-
ium had higher EDVi and ESVi, lower EF, and larger
entricular massi as compared with patients without
GE. Similar univariate analysis showed that LGE in the
ree wall of the primary ventricle and transmural LGE
ere both associated with larger ventricular volumes,
ecreased systolic function, and larger ventricular mass.
nivariate linear regression analysis revealed that higher
Patient CharacteristicsTable 1 Patient Characteristics
All Patients
(n  90)
Age at CMR (yrs) 23.1 10.9
Male 56 (62%)
Age at Fontan (yrs) 4.5 [2.0–11.3
Time since Fontan (yrs) 15.7 6.4
Cardiac diagnosis
Tricuspid atresia 24 (27%)
Double-inlet left ventricle 18 (20%)
Hypoplastic left heart syndrome 17 (19%)
Double-outlet right ventricle 14 (15%)
PA/IVS 6 (7%)
Atrioventricular canal defect 6 (7%)
Hypoplastic TV/RV 5 (5%)
Ventricular type
Left ventricle 46 (51%)
Right ventricle 30 (33%)
Mixed ventricle 14 (16%)
Fontan type
Lateral tunnel 51 (56%)
RA-to-pulmonary artery 29 (32%)
RA-to-RV 5 (6%)
Extracardiac 5 (6%)
Number of operations (before CMR) 3 [2–3]
Bypass procedures 2 [1–3]
Off-bypass procedures 1 [0–1]
Prior volume unloading surgery 33 (37%)
Age at volume unloading surgery 0.7 [0.4–1.4]
Number of catheterizations 4 [2–5]
History of Fontan revisions 11 (12%)
Heart transplant 2 (2%)
Death 4 (4%)
Values are expressed as mean  SD, n (%), or median [interquartile ra
‡Mann-Whitney U test.
CMR cardiac magnetic resonance; LGE late gadolinium enhance
atrium; RV  right ventricle; TV  tricuspid valve.ercent LGE was correlated with higher EDVi (R
2  t.27; p  0.001), higher ESVi (R
2  0.38; p  0.001),
ower EF (R2  0.32; p  0.001), and higher massi (R
2
0.16; p  0.001). There were no differences between
roups for SVi and mass-to-volume ratios. Similar results
ere observed when the contribution of EFE, septal
nsertion sites, and surgical sites were each removed from
he total percent LGE.
Multivariate linear regression analysis was performed to
etermine variables associated with EDVi, ESVi, EF, and
assi. Table 3 displays the final multivariate models for each
f the dependent CMR ventricular parameters. In the final
odels, higher percent LGE was associated with higher
DVi and ESVi, lower EF, and increased massi. Longer
ime since Fontan was also associated with lower EDVi and
assi, and older age at Fontan was associated with de-
reased EF.
Patients with LGE were more likely to have RWMA
52% vs. 28%; p  0.05). Compared with areas of RWMA
ithout LGE, LGE lesions with RWMA were more likely
LGE Absent
(n  65)
LGE Present
(n  25) p Value*
22.9 10.2 23.2 12.9 0.94
39 (60%) 17 (68%) 0.63†
3.1 [2.0–4.7] 3.1 [1.9–11.3] 0.56‡
16.2 5.9 14.3 7.7 0.20
0.29
17 (26%) 7 (28%)
16 (25%) 2 (8%)
10 (15%) 7 (28%)
11 (17%) 3 (12%)
4 (6%) 2 (8%)
5 (8%) 1 (4%)
2 (3%) 3 (12%)
0.11
34 (52%) 12 (48%)
24 (37%) 6 (24%)
7 (11%) 7 (28%)
0.20
36 (55%) 15 (60%)
24 (37%) 5 (20%)
3 (5%) 2 (8%)
2 (3%) 3 (12%)
3 [3–3] 3 [3–4] 0.67‡
3 [2–3] 3 [2–3] 0.20‡
0 [0–1] 0 [0–1] 0.31‡
22 (34%) 11 (44%) 0.47†
0.7 [0.5–1.5] 0.6 [0.4–1.4] 0.62‡
4 [2–6] 4 [2–6] 0.38‡
8 (12%) 3 (12%) 1.0†
2 (3%) 0 (0%) 1.0
2 (3%) 2 (8%) 0.3
Student t test or chi-square test of independence. †Fisher exact test.
A/IVS pulmonary atresia with intact ventricular septum; RA right]
nge]. *o have dyskinesis (78% vs. 22%; p  0.01).
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April 20, 2010:1721–8 Myocardial Fibrosis in Fontanrrhythmia results. Univariate results for history of ar-
hythmias are shown in Table 2. Patients with or without
GE were similar in terms of frequency of atrial arrhyth-
Figure 1 Locations and Patterns of LGE Late After Fontan Oper
(A) The arrow points to a transmural late gadolinium enhancement (LGE) lesion in
lesion with transmural extension in the free wall of the primary ventricle, whereas
dial LGE lesion in the free wall of the primary ventricle. (D) Speckled pattern (arro
Univariate AnalysisTable 2 Univariate Analysis
All Patients
(n  90)
EDVi (ml/BSA
1.3) 87 [66–108]
EDVi (ml/BSA) 100 [76–127]
ESVi (ml/BSA
1.3) 36 [27–53]
ESVi (ml/BSA) 41 [31–65]
SVi (ml/BSA) 55 18
EF (%) 53 12
Massi (g/BSA
1.3) 50 [41–69]
Massi (g/BSA) 57 [46–76]
Mass/volume ratio (g/ml) 0.6 [0.5–0.7]
RWMA 31 (34%)
Any ventricular arrhythmia 25 (28%)
Ventricular ectopy 19 (21%)
NSVT 17 (19%)
Sustained ventricular tachycardia 6 (7%)
Arrhythmia-related cardiac arrest 3 (3%)
Pacemaker 12 (13%)
Defibrillator 2 (2%)
Values are expressed as median [interquartile range], mean  SD, or
patients with exercise testing data: all patients, 38; without LGE, 24;BSA  body-surface area; EDV  end-diastolic volume; EF  ejection fracti
NSVT  nonsustained ventricular tachycardia; RWMA  regional wall motionias, including nonsinus rhythm, fibrillation, flutter, and
upraventricular tachycardia. Compared with patients
ithout LGE, those with LGE were more likely to have
the ventricular septum. (B) The arrowhead points to a primary subendocardial
l arrow identifies endocardial fibroelastosis. (C) The arrow points to a subepicar-
the free wall of the primary ventricle. LV  left ventricle; RV  right ventricle.
LGE Absent
(n  65)
LGE Present
(n  25) p Value
82 [63–98] 100 [79–158] 0.004†
95 [73–115] 123 [92–171] 0.003†
34 [26–44] 63 [35–87] 0.001†
39 [29–52] 66 [40–102] 0.001†
54 17 58 19 0.36*
56 10 45 14 0.001*
45 [38–59] 63 [49–89] 0.001†
52 [42–72] 73 [56–98] 0.001†
0.6 [0.5–0.8] 0.6 [0.5–0.7] 0.72†
18 (28%) 13 (52%) 0.05‡
13 (20%) 12 (48%) 0.02‡
9 (14%) 10 (40%) 0.01‡
7 (11%) 10 (40%) 0.005‡
3 (5%) 3 (12%) 0.3‡
1 (2%) 2 (8%) 0.2‡
10 (15%) 2 (8%) 0.5‡
2 (3%) 0 (0%) 1‡
Student t test. †Mann-Whitney U test. ‡Fisher exact test. §Number of
E, 14.ation
volving
the ful
ws) inn (%). *
with LGon; ESV  end-systolic volume; LGE  late gadolinium enhancement;
abnormalities; SV  stroke volume.
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Myocardial Fibrosis in Fontan April 20, 2010:1721–8entricular arrhythmias (40% vs. 14%; p  0.01) and
SVT (36% vs. 11%; p  0.01). With the exception of 1
atient who had an episode of ventricular tachycardia and
ardiac arrest after the CMR study, all other episodes of
entricular arrhythmia occurred before the date of the
MR examination. Multivariate logistic regression anal-
sis demonstrated that higher LGE percent (OR: 1.2;
5% CI: 1.1 to 1.4; p  0.006) was associated with higher
ncidence of NSVT.
xercise testing results. Of the 90 study patients, 38
42%) had a metabolic exercise test reaching maximal
erobic capacity within 1 year of their CMR study. Patients
ith or without positive LGE had a similar percent pre-
icted oxygen consumption, oxygen consumption at venti-
atory anaerobic threshold, oxygen pulse, and peak work-
oad. Results were similar if patients were analyzed by LGE
ocation or LGE pattern. There was no significant correla-
ion between any of the exercise data parameters and
ercent LGE.
iscussion
his study is the first to systematically evaluate myocardial
brosis as identified by the MDE technique in patients late
fter the Fontan operation. LGE was a common finding
nd was associated with a more dilated, hypertrophied, and
oorly functioning systemic ventricle and with a higher
requency of NSVT. Moreover, in multivariate analysis, the
ercent LGE in the ventricular myocardium was associated
ith parameters of adverse ventricular size and function, as
ell as an increased risk for ventricular tachycardia. Both
entricular systolic dysfunction and clinical arrhythmias
ave been shown to be important predictors of morbidity
nd mortality (2).
omparison with other studies. LGE has become a
ell-accepted marker for myocardial fibrosis and has been
Multivariate AnalysisTable 3 Multivariate Analysis
Outcome* Predictor
EDVi (mL/BSA
1.3)
Percent LGE
Time since Fontan
ESVi (mL/BSA
1.3)
Percent LGE
EF (%)
Percent LGE
Age at Fontan
Massi (g/BSA
1.3)
Percent LGE
Time since Fontan
Outcome†
NSVT
Percent LGE
*Multivariate linear regression analysis. †Multivariate logistic regress
Abbreviations as in Table 2.alidated histologically (4,16,17). Babu-Narayan et al. asso- Liated clinically important outcomes with LGE in adults
fter repair of tetralogy of Fallot and in patients with atrial
edirection surgery for transposition of the great arteries
7,8). In their studies, LGE was associated with decreased
xercise tolerance, higher New York Heart Association
unctional class, depressed RV systolic function, and in-
reased frequency of clinical arrhythmias and syncope.
imilar findings were recently reported by Wald et al. (12).
ur study did not find any associations between LGE and
xercise intolerance, but had similar results with regard to
GE and depressed ventricular function, RWMA, and
rrhythmias.
The Pediatric Heart Network (PHN) recently published
id-term outcomes in 546 patients after the Fontan oper-
tion, of whom 161 patients had a CMR study (1).
ompared with our study group, the PHN patients had
maller EDVi (85  25 ml/BSA
1.3 vs. 97  50 ml/BSA1.3;
 0.001) and had higher EF by CMR (57  10% vs. 53
12%; p  0.001). There are, however, significant differ-
nces between the 2 patient cohorts. Patients in the PHN
tudy were younger at the time of evaluation (age 11.9 3.4
ears vs. age 23.1 10.9 years; p 0.001), were more likely
o have had volume unloading surgery before their Fontan
75% vs. 38%; p  0.001), and were less likely to have had
right atrium-to-pulmonary artery Fontan (13% vs. 32%;
 0.001). These differences suggest that patients with
ontan physiology may have preserved ventricular mechan-
cs in the first and second decades of life, but that the risk of
dverse ventricular mechanics increases with time from their
ontan operation. This notion is supported by previously
ublished data showing increased morbidity and mortality
ith age after the Fontan operation (2,3).
linical implications. This study introduces MDE imag-
ng as a potential tool for risk stratification for this patient
opulation. In adult patients, the presence and extent of
ta SE p Value R2
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0.47
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April 20, 2010:1721–8 Myocardial Fibrosis in Fontanschemic heart disease, dilated and hypertrophic cardiomy-
pathy, arrhythmogenic RV cardiomyopathy, and other
onditions (18–21). It is therefore reasonable to explore
hether LGE and its extent could contribute to risk
tratification for heart failure and cardiac death late after the
ontan operation. For example, it would be beneficial to
ollow the PHN Fontan cohort with serial CMR and MDE
valuations to prospectively explore the temporal relation-
hip between LGE and adverse ventricular mechanics and
o study the implications of myocardial fibrosis.
tudy limitations. The single-center, retrospective nature
f our study limits our ability to make definitive conclusions
bout the impact of positive LGE on patient outcomes late
fter the Fontan operation. We have not followed these
atients long enough to know whether LGE is associated
ith important clinical outcomes such as cardiac transplan-
ation, implantable cardioverter-defibrillator implantation,
r death. Furthermore, this study was not designed to
dentify the root causes of myocardial fibrosis seen by MDE
maging. Although CMR has been widely adopted as the
referred technique by which to noninvasively follow these
atients (22), our cohort may not be a representative sample
f all patients late after the Fontan operation. Further,
DE technique was not applied uniformly to all patients
ndergoing a CMR examination after the Fontan opera-
ion. Logistic regression analysis demonstrated that this
eflects both an evolution in clinical practice and that in
ounger patients with a limited ability to cooperate with the
xamination, peripheral intravenous line placement poses a
hallenge. It is also worth noting that, as with any techno-
ogical advancement, the MDE technique evolved during
he study period, potentially increasing the sensitivity and
pecificity of the technique for later CMR examinations.
CMR evaluation in patients with pacemakers and defi-
rillators is currently a strong relative contraindication (23),
nd these patients are thus not represented in the study
ohort. In the cross-sectional PHN Fontan studies, 13% of
atients had such a device (1). This selection bias may result
n under-identification of ventricular arrhythmia events and
rrhythmia-related causes of sudden cardiac death in our
tudy. Patients with ventricular dysfunction may also be
ver-represented in this cohort, as these patients may
ndergo more frequent CMR surveillance compared with
atients who are asymptomatic.
onclusions
n patients late after the Fontan operation, the presence and
xtent of myocardial fibrosis as identified by LGE are
ssociated with dilated and hypertrophied systemic ventri-
les, systolic dysfunction, regional dyskinesis, and NSVT.
urther studies are warranted to examine the utility of LGE
or risk stratification and treatment decisions in patients
fter the Fontan operation.cknowledgment
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